Location History:
- Montréal, CA (2013)
- Montreal, CA (2008 - 2019)
Company Filing History:
1 out of 157 
1 out of 1 
1 out of 2 Years Active: 2008-2019
Title: The Innovative Contributions of Christiane Quiniou
Introduction
Christiane Quiniou is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of peptides that serve as CCR2 antagonists. With a total of four patents to her name, Quiniou's work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Among her latest patents, Quiniou has developed CCR2 antagonist peptides. One of her inventions relates to a peptide that functions as a CCR2 non-competitive antagonist. Another patent features a peptide comprising the amino acid sequence Thr-Phe-Leu-Lys or Thr-Phe-Leu-Lys-Cys, which is also useful as a CCR2 non-competitive antagonist peptide. These innovations highlight her expertise in peptide design and their applications in medical research.
Career Highlights
Christiane Quiniou has worked with prestigious institutions, including Université Pierre et Marie Curie (Paris 6) and Valorisation-Recherche Société En Commandite. Her experience in these organizations has allowed her to collaborate on various research projects, further enhancing her knowledge and skills in the field.
Collaborations
Quiniou has collaborated with notable professionals in her field, including Christophe Combadiere and Florian Sennlaub. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Christiane Quiniou's contributions to the field of biochemistry through her innovative patents demonstrate her commitment to advancing medical science. Her work on CCR2 antagonist peptides is a testament to her expertise and dedication to research.